Article History
Received: 1 February 2024
Revised: 16 April 2024
Accepted: 17 April 2024
First Online: 27 April 2024
Competing interests
: Ariana Chao has served on advisory boards to Eli Lilly and Boehringer Ingelheim and received grant support, on behalf of the University of Pennsylvania, from Eli Lilly and WW (Weight Watchers). Thomas Wadden serves on scientific advisory boards for Novo Nordisk and WW (Weight Watchers) and has received grant support, on behalf of the University of Pennsylvania, from Eli Lilly, Epitomee Medical, and Novo Nordisk. The other author has no conflicts of interest to disclose.